Accéder au contenu
Merck

Dynamic chromatin modification sustains epithelial-mesenchymal transition following inducible expression of Snail-1.

Cell reports (2013-12-24)
Sarah Javaid, Jianmin Zhang, Endre Anderssen, Josh C Black, Ben S Wittner, Ken Tajima, David T Ting, Gromoslaw A Smolen, Matthew Zubrowski, Rushil Desai, Shyamala Maheswaran, Sridhar Ramaswamy, Johnathan R Whetstine, Daniel A Haber
RÉSUMÉ

Epithelial-mesenchymal transition (EMT) is thought to contribute to cancer metastasis, but its underlying mechanisms are not well understood. To define early steps in this cellular transformation, we analyzed human mammary epithelial cells with tightly regulated expression of Snail-1, a master regulator of EMT. After Snail-1 induction, epithelial markers were repressed within 6 hr, and mesenchymal genes were induced at 24 hr. Snail-1 binding to its target promoters was transient (6-48 hr) despite continued protein expression, and it was followed by both transient and long-lasting chromatin changes. Pharmacological inhibition of selected histone acetylation and demethylation pathways suppressed the induction as well as the maintenance of Snail-1-mediated EMT. Thus, EMT involves an epigenetic switch that may be prevented or reversed with the use of small-molecule inhibitors of chromatin modifiers.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-fibronectine antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Kit d′amplification complète de génome entier (WGA) GenomePlex®, Optimized kit with enzyme for amplifying a variety of DNA including FFPE tissue
Sigma-Aldrich
Anti-acetyl-Histone H3 (Lys 4) Antibody, Upstate®, from rabbit